| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 9.029 | 41.920 | 75.685 | 138.266 | 194.913 | 145.009 | 135.008 |
| Total Income - EUR | - | - | - | 9.029 | 41.947 | 75.719 | 138.377 | 195.007 | 150.178 | 135.113 |
| Total Expenses - EUR | - | - | - | 10.698 | 36.553 | 72.291 | 111.713 | 153.030 | 129.837 | 134.788 |
| Gross Profit/Loss - EUR | - | - | - | -1.669 | 5.394 | 3.428 | 26.664 | 41.977 | 20.341 | 326 |
| Net Profit/Loss - EUR | - | - | - | -1.759 | 4.975 | 2.738 | 25.400 | 40.122 | 19.115 | 142 |
| Employees | - | - | - | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Agresearch Gep Trial Service S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 432 | 2.451 | 17.288 | 29.104 | 38.544 | 54.500 |
| Current Assets | - | - | - | 2.427 | 5.651 | 7.157 | 20.164 | 60.361 | 62.954 | 60.781 |
| Inventories | - | - | - | 676 | 0 | 0 | 0 | 593 | 414 | 579 |
| Receivables | - | - | - | 0 | 954 | 1.498 | 8.871 | 31.118 | 46.249 | 46.291 |
| Cash | - | - | - | 1.751 | 4.696 | 5.660 | 11.294 | 28.650 | 16.291 | 13.910 |
| Shareholders Funds | - | - | - | -1.694 | 3.313 | 5.988 | 31.256 | 71.475 | 90.373 | 90.010 |
| Social Capital | - | - | - | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | - | 4.122 | 2.769 | 3.620 | 6.196 | 17.989 | 11.125 | 31.606 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Agresearch Gep Trial Service S.r.l.